Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[In brief, our study demonstrated that CacyBP/SIP could enhance the MDR phenotype of pancreatic cancer cells by increasing the expression of P-gp and Bcl-2, thus inhibiting apoptosis of pancreatic cancer cell.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• assertion description "[In brief, our study demonstrated that CacyBP/SIP could enhance the MDR phenotype of pancreatic cancer cells by increasing the expression of P-gp and Bcl-2, thus inhibiting apoptosis of pancreatic cancer cell.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[In brief, our study demonstrated that CacyBP/SIP could enhance the MDR phenotype of pancreatic cancer cells by increasing the expression of P-gp and Bcl-2, thus inhibiting apoptosis of pancreatic cancer cell.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP885777.RARV8LOizl8YuqmvtfVTT5G3sQK2ZMetarhBcj8qhwHT8130_assertion description "[In brief, our study demonstrated that CacyBP/SIP could enhance the MDR phenotype of pancreatic cancer cells by increasing the expression of P-gp and Bcl-2, thus inhibiting apoptosis of pancreatic cancer cell.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP885777.RARV8LOizl8YuqmvtfVTT5G3sQK2ZMetarhBcj8qhwHT8130_provenance.
• NP843484.RAc3-1jzB52UuOaM1nSLSEJs8Gq8moOhxe_fknCd_-JVg130_assertion description "[In brief, our study demonstrated that CacyBP/SIP could enhance the MDR phenotype of pancreatic cancer cells by increasing the expression of P-gp and Bcl-2, thus inhibiting apoptosis of pancreatic cancer cell.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP843484.RAc3-1jzB52UuOaM1nSLSEJs8Gq8moOhxe_fknCd_-JVg130_provenance.
• NP963313.RAchgF1ZS1k0CBE3rxZOReCqbndT0YlYjEs9_w0npnU0I130_assertion description "[In brief, our study demonstrated that CacyBP/SIP could enhance the MDR phenotype of pancreatic cancer cells by increasing the expression of P-gp and Bcl-2, thus inhibiting apoptosis of pancreatic cancer cell.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP963313.RAchgF1ZS1k0CBE3rxZOReCqbndT0YlYjEs9_w0npnU0I130_provenance.
• NP968943.RAdvBAERmPjoDC69JOu4x5Yzwg7TRHo5Gu8iW9oyJqsaI130_assertion description "[In brief, our study demonstrated that CacyBP/SIP could enhance the MDR phenotype of pancreatic cancer cells by increasing the expression of P-gp and Bcl-2, thus inhibiting apoptosis of pancreatic cancer cell.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP968943.RAdvBAERmPjoDC69JOu4x5Yzwg7TRHo5Gu8iW9oyJqsaI130_provenance.
• NP1058062.RAaWloG1IQy4NvcRAjIJ8kWfQ0-sqygxSdbpaSu5nhdek130_assertion description "[In brief, our study demonstrated that CacyBP/SIP could enhance the MDR phenotype of pancreatic cancer cells by increasing the expression of P-gp and Bcl-2, thus inhibiting apoptosis of pancreatic cancer cell.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1058062.RAaWloG1IQy4NvcRAjIJ8kWfQ0-sqygxSdbpaSu5nhdek130_provenance.
• NP1015290.RAAhDNP0E4xZ02KMlGIQL0uCvQErE07gA499sgJ-P06l0130_assertion description "[In brief, our study demonstrated that CacyBP/SIP could enhance the MDR phenotype of pancreatic cancer cells by increasing the expression of P-gp and Bcl-2, thus inhibiting apoptosis of pancreatic cancer cell.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1015290.RAAhDNP0E4xZ02KMlGIQL0uCvQErE07gA499sgJ-P06l0130_provenance.
• NP1058057.RAB8xN-H3LbIhDZgnFvwZioZGSRp35MOkaS_TMWQySHT0130_assertion description "[In brief, our study demonstrated that CacyBP/SIP could enhance the MDR phenotype of pancreatic cancer cells by increasing the expression of P-gp and Bcl-2, thus inhibiting apoptosis of pancreatic cancer cell.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1058057.RAB8xN-H3LbIhDZgnFvwZioZGSRp35MOkaS_TMWQySHT0130_provenance.
• NP1058060.RAqug5MB3m0M1cZaQNmmzZhNv85EnSSf9A_kCvbilDlnI130_assertion description "[In brief, our study demonstrated that CacyBP/SIP could enhance the MDR phenotype of pancreatic cancer cells by increasing the expression of P-gp and Bcl-2, thus inhibiting apoptosis of pancreatic cancer cell.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1058060.RAqug5MB3m0M1cZaQNmmzZhNv85EnSSf9A_kCvbilDlnI130_provenance.
• NP1058065.RAuzsNOvLRntsliPY9MCYsCtL5lXJ9NQKIPkfbnpGD_z8130_assertion description "[In brief, our study demonstrated that CacyBP/SIP could enhance the MDR phenotype of pancreatic cancer cells by increasing the expression of P-gp and Bcl-2, thus inhibiting apoptosis of pancreatic cancer cell.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1058065.RAuzsNOvLRntsliPY9MCYsCtL5lXJ9NQKIPkfbnpGD_z8130_provenance.
• NP963315.RAIxrNjOg9HRiKsVLyYanWBhi0DKItRrOGeDV7n85JRSs130_assertion description "[In brief, our study demonstrated that CacyBP/SIP could enhance the MDR phenotype of pancreatic cancer cells by increasing the expression of P-gp and Bcl-2, thus inhibiting apoptosis of pancreatic cancer cell.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP963315.RAIxrNjOg9HRiKsVLyYanWBhi0DKItRrOGeDV7n85JRSs130_provenance.
• NP968941.RAPjNGP_aXJxTR7lNui-_n6Bny3OdO9ECDPiIPM-016rg130_assertion description "[In brief, our study demonstrated that CacyBP/SIP could enhance the MDR phenotype of pancreatic cancer cells by increasing the expression of P-gp and Bcl-2, thus inhibiting apoptosis of pancreatic cancer cell.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP968941.RAPjNGP_aXJxTR7lNui-_n6Bny3OdO9ECDPiIPM-016rg130_provenance.
• NP1058058.RANX3RtVFTYKwrqz0tO5LdyG3yKtJeVFtdpafSHEK2tFQ130_assertion description "[In brief, our study demonstrated that CacyBP/SIP could enhance the MDR phenotype of pancreatic cancer cells by increasing the expression of P-gp and Bcl-2, thus inhibiting apoptosis of pancreatic cancer cell.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1058058.RANX3RtVFTYKwrqz0tO5LdyG3yKtJeVFtdpafSHEK2tFQ130_provenance.
• NP1058061.RANKXE7URQLjvXrIacgj8F71d4K5_0D51U0V2f9vWi02Q130_assertion description "[In brief, our study demonstrated that CacyBP/SIP could enhance the MDR phenotype of pancreatic cancer cells by increasing the expression of P-gp and Bcl-2, thus inhibiting apoptosis of pancreatic cancer cell.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1058061.RANKXE7URQLjvXrIacgj8F71d4K5_0D51U0V2f9vWi02Q130_provenance.
• NP843486.RANVM6C2WuOihO8j0ySzInmnVIoZyOtbT_tZqzi35maFE130_assertion description "[In brief, our study demonstrated that CacyBP/SIP could enhance the MDR phenotype of pancreatic cancer cells by increasing the expression of P-gp and Bcl-2, thus inhibiting apoptosis of pancreatic cancer cell.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP843486.RANVM6C2WuOihO8j0ySzInmnVIoZyOtbT_tZqzi35maFE130_provenance.
• NP880515.RAKjnxhpJB3qOIdNeOAeHW3zxyXkKSZPQ9lsQgMkic4mE130_assertion description "[In brief, our study demonstrated that CacyBP/SIP could enhance the MDR phenotype of pancreatic cancer cells by increasing the expression of P-gp and Bcl-2, thus inhibiting apoptosis of pancreatic cancer cell.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP880515.RAKjnxhpJB3qOIdNeOAeHW3zxyXkKSZPQ9lsQgMkic4mE130_provenance.
• NP1015292.RAKog9_WqOkz3LuHCtfmYqkz6j29HJjcN9gt_rLTJr55A130_assertion description "[In brief, our study demonstrated that CacyBP/SIP could enhance the MDR phenotype of pancreatic cancer cells by increasing the expression of P-gp and Bcl-2, thus inhibiting apoptosis of pancreatic cancer cell.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1015292.RAKog9_WqOkz3LuHCtfmYqkz6j29HJjcN9gt_rLTJr55A130_provenance.
• NP880518.RA0NtesAVKp4g5DHkbSlz5mC-w2JChpOSovZ6j5XovAQI130_assertion description "[In brief, our study demonstrated that CacyBP/SIP could enhance the MDR phenotype of pancreatic cancer cells by increasing the expression of P-gp and Bcl-2, thus inhibiting apoptosis of pancreatic cancer cell.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP880518.RA0NtesAVKp4g5DHkbSlz5mC-w2JChpOSovZ6j5XovAQI130_provenance.
• NP1058056.RA6aRAI7fnbiv6YSyY_7TaaTZ1esGeDLmPP-ESMp5I4mI130_assertion description "[In brief, our study demonstrated that CacyBP/SIP could enhance the MDR phenotype of pancreatic cancer cells by increasing the expression of P-gp and Bcl-2, thus inhibiting apoptosis of pancreatic cancer cell.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1058056.RA6aRAI7fnbiv6YSyY_7TaaTZ1esGeDLmPP-ESMp5I4mI130_provenance.
• NP1058059.RA8IkXIBSH2gy9_0Ga9dPE3u63JhUV2kDzUTElfPVE0jw130_assertion description "[In brief, our study demonstrated that CacyBP/SIP could enhance the MDR phenotype of pancreatic cancer cells by increasing the expression of P-gp and Bcl-2, thus inhibiting apoptosis of pancreatic cancer cell.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1058059.RA8IkXIBSH2gy9_0Ga9dPE3u63JhUV2kDzUTElfPVE0jw130_provenance.
• NP1058063.RAxP1k-HuaZk1k6hMH5sLpEOQYi0bTIHug8Iuh8rlq8hU130_assertion description "[In brief, our study demonstrated that CacyBP/SIP could enhance the MDR phenotype of pancreatic cancer cells by increasing the expression of P-gp and Bcl-2, thus inhibiting apoptosis of pancreatic cancer cell.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1058063.RAxP1k-HuaZk1k6hMH5sLpEOQYi0bTIHug8Iuh8rlq8hU130_provenance.
• NP1058064.RA7AGrJ4eCWrgmrbwAWk50gDotblGqXMWXxJ8Y53EYBNE130_assertion description "[In brief, our study demonstrated that CacyBP/SIP could enhance the MDR phenotype of pancreatic cancer cells by increasing the expression of P-gp and Bcl-2, thus inhibiting apoptosis of pancreatic cancer cell.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1058064.RA7AGrJ4eCWrgmrbwAWk50gDotblGqXMWXxJ8Y53EYBNE130_provenance.
• NP885775.RA9JPS6Ax21jpYcHev2uPzS2kQZxpUfUVkJLZ37NlLXb8130_assertion description "[In brief, our study demonstrated that CacyBP/SIP could enhance the MDR phenotype of pancreatic cancer cells by increasing the expression of P-gp and Bcl-2, thus inhibiting apoptosis of pancreatic cancer cell.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP885775.RA9JPS6Ax21jpYcHev2uPzS2kQZxpUfUVkJLZ37NlLXb8130_provenance.